Drug Development

Recently identified cell-cycle controls are targets for new drugs that fight infections by shutting down division.
| 5 min read

Malvern Instruments Ltd. (Malvern, UK) announced today (June 4) that it has entered into an agreement with GE Healthcare Life Sciences to acquire the company’s MicroCal™ microcalorimetry business. Financial terms were not disclosed. The acquisition, which is subject to regulatory approvals, is expected to complete in the third quarter of 2014.
| 1 min read














